drugset / Trial / NCT00992537
Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics
RandomizedCrossoverOpen-labelTreatment
Summary
This trial is conducted in Europe. The aim of this clinical trial is to compare the blood glucose lowering effect of NN5401(insulin degludec/insulin aspart (IDegAsp)) with NN1250 (insulin degludec (IDeg)) and insulin aspart (IAsp) in subjects with type 1 diabetes where the trial participant will receive one single dose of each trial product in varying order.
Timeline
- Start
- 2009-10
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | insulin aspart | Protein / enzyme biologic | 0.5 iu/kg | Subcutaneous |
| Subject | insulin degludec | Protein / enzyme biologic | 0.5 iu/kg | Subcutaneous |
| Subject | insulin degludec/insulin aspart | Unknown | 0.5 iu/kg | Subcutaneous |